Month: August 2024
NewsWare’s Trade Talk: Thursday, August 1 | NewsWare‘s Trade Talk
S&P Futures are higher in the pre-market as markets react to the positive earnings results from META. After the bell today we hear from AAPL, AMZN & INTC. Sentiment is positive as Fed officials appear set to being loosening monetary policy in September. A rate decision from the BOE it due today, Japan’s rate increase is strengthening the yen, causing Japanese equities to slide. Jobless Claims & Manufacturing PMI data on tap for release today. In Europe, markets are weaker due to downbeat earnings in the auto sector. Oil continues to gain on the threat of escalating tensions in the Middle East.
– YouTube
Mr. Biden has had 6 covid shots and covid infection 3 times.
Results, Increased incidence of MCI and AD in vaccinated individuals,
particularly those receiving mRNA vaccines,
within three months post-vaccination.
mRNA vaccine group
AD, Odds Ratio: 1.225
p = 0.026
MCI, Odds Ratio: 2.377
p less than 0.001
No significant relationship was found with vascular dementia or Parkinson's disease.
October 2022, Biden receives new COVID-19 booster
A potential association between COVID-19 vaccination and development of Alzheimer’s disease
28 May 2024
https://pubmed.ncbi.nlm.nih.gov/38806183/
https://academic.oup.com/qjmed/advance-article-abstract/doi/10.1093/qjmed/hcae103/7684274?login=false
Background
Concerns about vaccine side effects, particularly potential links to neurodegenerative diseases such as Alzheimer's disease (AD).
Aim
This study investigates the association between COVID-19 vaccination and the onset of AD,
and it’s prodromal state, mild cognitive impairment (MCI).
Design
A nationwide, retrospective cohort study
Korean National Health Insurance Service.
Data recorded 3 months after vaccination
Methods
Seoul, South Korea,
analyzed data from a random 50% sample,
aged 65 and above,
n = 558,017.
Vaccinated group
Unvaccinated group
Patients with vascular dementia or Parkinson's disease served as controls.
Conclusions
Preliminary evidence suggests a potential link between COVID-19 vaccination,
particularly mRNA vaccines,
and increased incidences of AD and MCI.
Need for further research to elucidate the relationship between vaccine-induced immune responses and neurodegenerative processes,
advocating for continuous monitoring and investigation into the vaccines' long-term neurological impacts.
Roh JH, Jung I, Suh Y, Kim MH. A potential association between COVID-19 vaccination and development of alzheimer's disease. QJM. 2024 May 28:hcae103. doi: 10.1093/qjmed/hcae103. Epub ahead of print. PMID: 38806183.